AIF1 Gene

AIF1 Gene

Overview

Aif1 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Pathway Diagram

AIF1 Gene

Overview

Aif1 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Pathway Diagram

Knowledge graph relationships for AIF1 (307 total edges in KG)

Introduction

AIF1 (allograft inflammatory factor 1; IBA1) encodes a calcium-binding cytoskeletal adaptor that is strongly enriched in [microglia](/cell-types/microglia). In neurodegenerative disease research, AIF1 is used as a core readout for microglial recruitment, morphology, and activation state around pathology such as [amyloid-beta](/proteins/amyloid-beta), [tau](/proteins/tau), and [alpha-synuclein](/proteins/alpha-synuclein).[@imai1996][@kerenshaul2017]

<div class="infobox infobox-gene">
<table>
<tr><th>Gene Symbol</th><td>AIF1</td></tr>
<tr><th>Full Name</th><td>Allograft Inflammatory Factor 1</td></tr>
<tr><th>Common Alias</th><td>IBA1</td></tr>
<tr><th>Chromosomal Location</th><td>6p21.3</td></tr>
<tr><th>NCBI Gene ID</th><td>199</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000240065</td></tr>
<tr><th>UniProt ID</th><td>P55072</td></tr>
<tr><th>Primary Cell Context</th><td>Microglia and infiltrating myeloid cells</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">ALZHEIMER</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">154 edges</a></td>
</tr>
</table>
</div>

Molecular Function

AIF1 is an EF-hand calcium-binding protein that couples inflammatory signaling to actin remodeling. In activated [microglia](/cell-types/microglia-neuroinflammation) it supports membrane ruffling, process extension/retraction, migration toward chemotactic signals, and phagocytic cup formation.[@imai1996][@ohsawa2001] Because these behaviors are central to tissue surveillance and debris clearance, AIF1 expression generally rises as microglia transition from homeostatic states to injury- or disease-responsive states.[@kerenshaul2017][@krasemann2017]

Key functional themes include:

• Calcium-dependent regulation of actin dynamics
• Phagocytosis and lysosomal cargo handling in response to protein aggregates
• Integration with [complement system](/mechanisms/complement-system-neurodegeneration) driven synapse and debris clearance
• Participation in inflammatory reprogramming alongside [TREM2](/genes/trem2), [APOE](/genes/apoe), and [TYROBP](/genes/tyrobp) modules[@kerenshaul2017][@krasemann2017]

Role in Neurodegeneration

Alzheimer's disease

In [Alzheimer's disease](/diseases/alzheimers-disease), AIF1-positive microglia accumulate around plaques and dystrophic neurites, where they can provide both protective and harmful effects depending on timing and state.[@kerenshaul2017][@heneka2015] Early responses may support compaction/containment of amyloid deposits, but chronic inflammatory signaling is associated with synaptic stress and network dysfunction.[@heneka2015][@shi2018]

AIF1 staining is therefore interpreted together with disease-stage markers and signaling pathways such as [NLRP3 inflammasome](/mechanisms/nlrp3-inflammasome-pathway-neurodegeneration), [NF-kB](/mechanisms/nf-kb-signaling-neurodegeneration), and [microglia-neuroinflammation](/mechanisms/microglia-neuroinflammation).

Parkinson's disease

In [Parkinson's disease](/diseases/parkinsons-disease), AIF1-positive microglia are increased in vulnerable regions including [substantia nigra](/brain-regions/substantia-nigra).[@hirsch1931] Interaction with neuronal [alpha-synuclein](/proteins/alpha-synuclein) species can amplify cytokine signaling and oxidative stress programs that contribute to dopaminergic vulnerability.[@hirsch1931][@pajares2019]

ALS and related motor disorders

In [amyotrophic lateral sclerosis](/diseases/amyotrophic-lateral-sclerosis), elevated AIF1 signal is commonly observed in spinal and corticospinal compartments and tracks with myeloid activation around degenerating motor units.[@geloso2017] Similar patterns are reported across frontotemporal and multisystem neurodegenerative syndromes with strong neuroimmune components.[@heneka2015][@geloso2017]

Mechanistic Position in the Gene-Protein-Pathway Axis

AIF1 can be placed in a practical mechanistic chain:

This framing links AIF1 to broader pathways in [selective neuronal vulnerability](/mechanisms/selective-neuronal-vulnerability), [oxidative stress](/mechanisms/oxidative-stress), and [complement-mediated-synapse-loss](/mechanisms/complement-mediated-synapse-loss).

Biomarker and Translational Relevance

AIF1 is primarily a tissue-level and imaging-adjacent marker rather than a standalone circulating diagnostic biomarker. Its translational value is strongest when integrated with multimodal readouts:

• Histopathology: microglial burden and morphology
• Transcriptomics: homeostatic-to-inflammatory state transitions
• Imaging/pathology correlation with amyloid/tau/alpha-syn pathology load
• Intervention studies targeting [TREM2 therapeutics](/therapeutics/trem2-therapeutics), complement signaling, or inflammasome pathways[@krasemann2017][@heneka2015][@shi2018]

Open Questions

• Which AIF1-associated microglial states are compensatory vs pathogenic across disease stages?
• How should AIF1 be combined with state-specific markers (for example, DAM and interferon-response modules) in trial stratification?
• Can therapies that reduce harmful neuroinflammation preserve beneficial phagocytic functions in AIF1-high populations?

See Also

• [Microglia](/cell-types/microglia) — Resident immune cells of the CNS where AIF1 is predominantly expressed
• [Neuroinflammation](/mechanisms/neuroinflammation-pathway) — Inflammatory processes in neurodegeneration mediated by microglia
• [TREM2](/genes/trem2) — Triggering receptor expressed on myeloid cells 2, another key microglial marker
• [Iba1 Protein](/iba1-protein) — Alternative name for AIF1 protein
• [Parkinson's Disease](/diseases/parkinsons-disease) — AD-linked proteinopathies and synucleinopathies
• [Alzheimer's Disease](/diseases/alzheimers-disease) — Major neurodegenerative disease with neuroinflammation component

External Links

• [NCBI Gene: AIF1](https://www.ncbi.nlm.nih.gov/gene/199)
• [UniProt: IBA1 (P35080)](https://www.uniprot.org/uniprot/P35080)
• [GeneCards: AIF1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=AIF1)
• [HGNC: AIF1](https://www.genenames.org/data/hgnc_complete_set.txt?search=AIF1)

Overview

Aif1 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Background

The study of Aif1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Experimental Systems and Interpretation Caveats

AIF1 is often treated as a binary marker of "activated" microglia, but modern single-cell and spatial profiling shows that AIF1-high cells span multiple states with different functional consequences.[@kerenshaul2017][@krasemann2017] In practice, interpretation should be paired with state-defining markers (for example, lipid-handling, interferon-response, and antigen-presentation modules), regional context, and pathology stage.[@krasemann2017][@shi2018]

Preclinical studies commonly combine AIF1 immunoreactivity with readouts of autophagy, synaptic density, and complement deposition to distinguish whether interventions shift microglia toward clearance-supportive versus injury-amplifying programs.[@heneka2015][@shi2018] This is especially relevant for trials targeting TREM2 therapeutics, NLRP3 inflammasome, or cytokine cascades, where preserving beneficial debris handling is a major translational constraint.[@heneka2015][@geloso2017]

References

Pathway Diagram

The following diagram shows the key molecular relationships involving AIF1 Gene discovered through SciDEX knowledge graph analysis: